首页> 外文期刊>Movement disorders >Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy
【24h】

Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy

机译:美国国家神经疾病和中风/学会进行性核上性麻痹的准确性以及帕金森综合症的神经保护和自然病史以及诊断进行性核上性麻痹的标准

获取原文
获取原文并翻译 | 示例
           

摘要

Autopsy is the diagnostic gold standard for progressive supranuclear palsy (PSP). The National Institute of Neurological Disorders and Stroke and Society for Progressive Supranuclear Palsy (NINDS-SPSP) criteria for the clinical diagnosis of "probable" PSP are thought to possess high specificity and low sensitivity. The NINDS-SPSP criteria for "possible" PSP are considered to increase sensitivity at the expense of specificity. The Neuroprotection and Natural History in Parkinson Plus Syndromes (NNIPPS) criteria are intended to improve sensitivity while maintaining high specificity. The aim of this study was to conduct a clinicopathological evaluation of the NINDS-SPSP and NNIPPS criteria in tertiary neurological centers. Defined clinical features and their year of onset were recorded by chart review in neuropathologically diagnosed patients with PSP, Parkinsons's disease (PD), MSA parkinsonism and corticobasal degeneration from four European brain banks. Fulfilment of the clinical diagnostic criteria was verified for each year after disease onset and for the final antemortem record. We analyzed 98 PSP patients and 46 disease controls. The NINDS-SPSP "probable" criteria yielded shorter time to diagnosis, slightly higher specificity and positive predictive value (PPV), and similar sensitivity, compared with the NNIPPS criteria. Unexpectedly, the NINDS-SPSP "possible" criteria yielded the lowest sensitivity, specificity, and PPV. A combination of NINDS-SPSP possible and probable criteria yielded the highest sensitivity. We suggest that the NINDS-SPSP probable criteria might be preferred for recruitment of patients for clinical trials, where an early and specific diagnosis is important. For routine clinical care, where high sensitivity is crucial, a combination of NINDS possible and probable criteria might be preferred.
机译:尸检是进行性核上性麻痹(PSP)的诊断金标准。美国国家神经病学和中风学会以及进行性核上性麻痹协会(NINDS-SPSP)对“可能” PSP进行临床诊断的标准被认为具有高特异性和低敏感性。 “可能的” PSP的NINDS-SPSP标准被认为是以增加特异性为代价来提高灵敏度。帕金森综合症(NNIPPS)标准中的神经保护和自然史旨在提高敏感性,同时保持高特异性。这项研究的目的是在三级神经病学中心对NINDS-SPSP和NNIPPS标准进行临床病理评估。通过图表回顾记录了来自四个欧洲脑库的PSP,帕金森氏病(PD),MSA帕金森病和皮质基底变性的神经病理学诊断患者的明确临床特征及其发病年份。在疾病发作后的每年以及最终的死前记录中,都要验证是否符合临床诊断标准。我们分析了98名PSP患者和46名疾病对照。与NNIPPS标准相比,NINDS-SPSP“可能”标准产生的诊断时间更短,特异性和阳性预测值(PPV)略高,敏感性相似。出乎意料的是,NINDS-SPSP的“可能”标准产生了最低的敏感性,特异性和PPV。 NINDS-SPSP可能标准和可能标准的组合产生了最高的灵敏度。我们建议NINDS-SPSP可能的标准可能更适合于招募患者进行临床试验,因为早期和特定的诊断很重要。对于高度敏感至关重要的常规临床护理,可能首选NINDS结合可能的标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号